Get the Stockscreener App
12.52
0.40%
0.05
After Hours:
12.52
Tyra Biosciences Inc stock is traded at $12.52, with a volume of 196.34K.
It is up +0.40% in the last 24 hours and up +18.11% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$12.47
Open:
$12.47
24h Volume:
196.34K
Relative Volume:
0.74
Market Cap:
$667.28M
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-7.7764
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
-1.03%
1M Performance:
+18.11%
6M Performance:
+15.71%
1Y Performance:
-39.08%
1-Day Range:
$12.24
$12.56
1-Week Range:
$11.70
$12.62
52-Week Range:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
12.52 | 634.77M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Automated trading signals detected on Tyra Biosciences Inc.Treasury Yields & Low Drawdown Trading Techniques - Newser
Tyra Biosciences, Inc. $TYRA Position Increased by Polar Asset Management Partners Inc. - MarketBeat
Visualizing Tyra Biosciences Inc. stock with heatmapsEarnings Risk Report & Verified Swing Trading Watchlists - Newser
What Fibonacci levels say about Tyra Biosciences Inc. reboundEarnings Performance Report & Risk Managed Trade Strategies - Newser
Can trapped investors hope for a rebound in Tyra Biosciences Inc.Portfolio Growth Summary & Community Supported Trade Ideas - Newser
Is Tyra Biosciences Inc. still worth holding after the dipJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Using data tools to time your Tyra Biosciences Inc. exitTrade Risk Report & Risk Adjusted Buy and Sell Alerts - Newser
Tyra Biosciences, Inc. $TYRA Shares Acquired by Jacobs Levy Equity Management Inc. - MarketBeat
Candlestick signals on Tyra Biosciences Inc. stock todayWeekly Trade Summary & Community Consensus Trade Signals - Newser
What MACD and RSI say about Tyra Biosciences Inc.July 2025 PreEarnings & Precise Buy Zone Identification - Newser
Understanding Tyra Biosciences Inc.’s price movementTrade Entry Summary & Daily Growth Stock Investment Tips - Newser
Nuveen LLC Takes $465,000 Position in Tyra Biosciences, Inc. $TYRA - MarketBeat
Pattern recognition hints at Tyra Biosciences Inc. upsideEntry Point & Fast Moving Market Watchlists - Newser
Tyra Biosciences Inc. stock trendline breakdownWeekly Profit Analysis & Safe Entry Zone Identification - Newser
Is Tyra Biosciences Inc. meeting your algorithmic filter criteriaTreasury Yields & Free Real-Time Volume Trigger Notifications - Newser
Can Tyra Biosciences Inc. hit a new high this monthDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Oppenheimer Adjusts Price Target on Tyra Bioscience to $36 From $30, Maintains Outperform Rating - MarketScreener
Real time social sentiment graph for Tyra Biosciences Inc.2025 Trading Volume Trends & Daily Profit Maximizing Tips - Newser
Will Tyra Biosciences Inc. stock recover after recent dropPortfolio Risk Summary & Risk Controlled Daily Trade Plans - Newser
Volatility clustering patterns for Tyra Biosciences Inc.Market Risk Analysis & Low Risk Investment Opportunities - Newser
Is it too late to sell Tyra Biosciences Inc.July 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - Newser
What technical models suggest about Tyra Biosciences Inc.’s comebackQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
What recovery options are there for Tyra Biosciences Inc.M&A Rumor & Fast Entry High Yield Stock Tips - Newser
price momentum metrics for tyra biosciences inc. explainedOptions Play & Long-Term Investment Growth Plans - Newser
Live market analysis of Tyra Biosciences Inc.Treasury Yields & Long-Term Growth Plans - Newser
Live Scanner Shows Breakout on Tyra Biosciences Inc.Weekly Stock Recap & Advanced Swing Trade Entry Alerts - beatles.ru
Technical analysis overview for Tyra Biosciences Inc. stockJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
is tyra biosciences inc. stock bottoming out2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Recovery Setup Building in Tyra Biosciences Inc. Experts SayBear Alert & Daily Risk Controlled Trade Plans - beatles.ru
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):